Yet, for Bo and the rest of Blue Sparrows, it was very clear why they should focus on that specific group. They look mainly at the financial aspects, while we look at the product, the business model and the team – and help make adjustments where necessary.” Focusing on early-stage medtech startups – a conscious choiceĪ lot of people might think that investing in an early-stage, innovative company is risky business. And because we are entrepreneurs, we can determine that way more clearly than fund managers can. “We are entrepreneurs and not fund managers, so we can determine from our own experience whether a specific proposition has the potential to be successful. They also look beyond the financials and at the potential that a startup holds. As a team, they believe that adding actionable knowledge and experience to a company early on can significantly increase their chance of success. “We can help startups on a very operational level – from validating their idea or already existing product, to creating a business model that works, to clinical validation and medical certification,” says Bo. They have been through the ups and downs of being an early-stage company and can guide current startups to success, while avoiding the mistakes that they had once made. Having built – and some even sold – their own business in the medtech sector, Bo and the rest of the team know what it takes to create a company from scratch. What makes Blue Sparrows different from other funds is that while it does have people with an investment background onboard, it is first of all run by entrepreneurs. Today, it also has two experienced fund managers onboard, whose expertise complements the entrepreneurial experience of the rest of the team. It took Bo and the rest of the team about four years to set the fund up and get it to do what it was meant to do – invest in high-potential medtech companies from across the country. “Because we were such a strong group of entrepreneurs, we got many requests from other medtech founders to provide advice or coaching, so we came up with the idea of setting up our own investment fund.” “We are all entrepreneurs from YES!Delft and this is where it all started back in 2014,” says Bo. As of a few years ago, he is also the co-founder of Blue Sparrows, an investment fund for early-stage medtech companies.īo started Blue Sparrows together with six fellow medtech entrepreneurs and as a group, they are an example of what networking at YES!Delft can lead to. This time focused on medtechīo Wiesman is a seasoned entrepreneur and the CEO of NewCompliance, an innovative company that offers predictive dashboarding and analytics solutions to hospitals. And every so often, that network yields some pretty interesting collaborations. They introduce them to a network of fellow innovators that they can draw resources and inspiration from. Incubators and communities like YES!Delft are there to offer startups the support and know-how they need to start their innovative businesses and grow.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |